• Bookmark and Share
  • Printer Friendly
  • Text Resizer - Small
  • Text Resizer - Large
  • Email this page

NPS News 37: Mind the gaps: how much do we really know about new drugs?

Description: Cautious approach to new drugs, given the limitations of evidence, failure of clinical trials to define safety profiles and side effects revealed by postmarketing surveillance.

Download Adobe Acrobat Reader

This document is a PDF file. To view PDF documents you will need to download Adobe Reader from the Adobe website.

Please don't show me this PDF gateway page again for this browser session (this will reset when the browser is closed).

This site complies to the HONcode standard for trustworthy health information: verify here.
Health Insite Logo This website is certified by Health On the Net Foundation. Click to verify.